Emerging Pathways of Action of Eicosapentaenoic Acid (EPA)

被引：1

作者：

Bhatt, Deepak L. ^{[1
]}

Libby, Peter ^{[2
]}

Mason, R. Preston ^{[2
,3
]}

机构：

[1] Mt Sinai Fuster Heart Hosp, Icahn Sch Med Mt Sinai, 1 Gustave Levy Pl,Box 1030, New York, NY 10029 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA USA

[3] Elucida Res, Beverly, MA USA

来源：

JACC-BASIC TO TRANSLATIONAL SCIENCE | 2025年 / 10卷 / 03期

关键词：

eicosapentaenoic acid; inflammation; omega-3 fatty acids; EVENTS;

D O I：

10.1016/j.jacbts.2024.10.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：396 / 400

页数：5

共 10 条

[1] Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles [J].

Bhatt, Deepak L. ;

Steg, Ph. Gabriel ;

Miller, Michael ;

Brinton, Eliot A. ;

Jacobson, Terry A. ;

Jiao, Lixia ;

Tardif, Jean-Claude ;

Gregson, John ;

Pocock, Stuart J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (08) :1159-1161

[2] Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia [J].

Bhatt, Deepak L. ;

Steg, P. Gabriel ;

Miller, Michael ;

Brinton, Eliot A. ;

Jacobson, Terry A. ;

Ketchum, Steven B. ;

Doyle, Ralph T., Jr. ;

Juliano, Rebecca A. ;

Jiao, Lixia ;

Granowitz, Craig ;

Tardif, Jean-Claude ;

Ballantyne, Christie M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) :11-22

[3] Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis [J].

Khan, Safi U. ;

Lone, Ahmad N. ;

Khan, Muhammad Shahzeb ;

Virani, Salim S. ;

Blumenthal, Roger S. ;

Nasir, Khurram ;

Miller, Michael ;

Michos, Erin D. ;

Ballantyne, Christie M. ;

Boden, William E. ;

Bhatt, Deepak L. .

ECLINICALMEDICINE, 2021, 38

[4] Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid [J].

Mason, R. Preston ;

Libby, Peter ;

Bhatt, Deepak L. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (05) :1135-1147

[5] Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA) [J].

Miyauchi, Katsumi ;

Iwata, Hiroshi ;

Nishizaki, Yuji ;

Inoue, Teruo ;

Hirayama, Atsushi ;

Kimura, Kazuo ;

Ozaki, Yukio ;

Murohara, Toyoaki ;

Ueshima, Kenji ;

Kuwabara, Yoshihiro ;

Tanaka-Mizuno, Sachiko ;

Yanagisawa, Naotake ;

Sato, Tosiya ;

Daida, Hiroyuki .

CIRCULATION, 2024, 150 (06) :425-434

[6] Benefit of icosapent ethyl on coronary physiology assessed by computed tomography angiography fractional flow reserve: EVAPORATE-FFRCT [J].

Rabbat, Mark G. ;

Lakshmanan, Suvasini ;

Benjamin, Mina M. ;

Doros, Gheorghe ;

Kinninger, April ;

Budoff, Matthew J. ;

Bhatt, Deepak L. .

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2023, 24 (07) :866-873

[7]

Reilly NA, 2024, bioRxiv, DOI 10.1101/2024.03.15.585315

[8] Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials [J].

Ridker, Paul M. ;

Bhatt, Deepak L. ;

Pradhan, Aruna ;

Glynn, Robert J. ;

MacFadyen, Jean G. ;

Nissen, Steven E. .

LANCET, 2023, 401 (10384) :1293-1301

[9] Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation [J].

Sherratt, Samuel C. R. ;

Libby, Peter ;

Dawoud, Hazem ;

Bhatt, Deepak L. ;

Mason, R. Preston .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (14)

[10] Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis [J].

Yokoyama, Mitsuhiro ;

Origasa, Hideki ;

Matsuzaki, Masunori ;

Matsuzawa, Yuji ;

Saito, Yasushi ;

Ishikawa, Yuichi ;

Oikawa, Shinichi ;

Sasaki, Jun ;

Hishida, Hitoshi ;

Itakura, Hiroshige ;

Kita, Toru ;

Kitabatake, Akira ;

Nakaya, Noriaki ;

Sakata, Toshiie ;

Shimada, Kazuyuki ;

Shirato, Kunio .

LANCET, 2007, 369 (9567) :1090-1098

← 1 →